首頁 > 市場調查報告書 > 製藥

疼痛

Ibuprofen原料藥市場規模、佔有率和成長分析（按應用、製劑類型和地區分類）－2025-2032年產業預測

市場調查報告書

商品編碼

1871727

Ibuprofen原料藥市場規模、佔有率和成長分析（按應用、製劑類型和地區分類）－2025-2032年產業預測

Ibuprofen API Market Size, Share, and Growth Analysis, By Application (Pharmaceuticals, Consumer Healthcare), By Formulation Type (Tablets, Oral), By Region - Industry Forecast 2025-2032

出版日期: 2025年11月13日 | 出版商:

SkyQuest | 英文 175 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

世界のIbuprofen原料藥市場規模は、2023年に62億米ドルと評価され、2024年の64億6,000万米ドルから2032年までに89億8,000万米ドルへ成長する見込みです。予測期間（2025年～2032年）におけるCAGRは4.2％と予測されています。

由於醫療保健服務可近性的提高、人口老化以及學名藥的日益普及，全球Ibuprofen原料藥市場正經歷顯著成長。處方藥和非處方藥領域對消炎鎮痛產品的需求激增，推動了這一成長趨勢。推動市場擴張的關鍵因素包括全球人口老化、醫療保健服務可近性的提高以及消費者對經濟實惠的學名藥的偏好。北美和歐洲由於對高品質原料藥的持續需求而佔據了相當大的市場佔有率，但原料成本波動和監管壁壘等挑戰可能會威脅到業務營運的穩定性。亞太地區的市場前景依然樂觀，尤其是在產能和出口量方面處於主導地位，預計這些因素將在近期影響市場趨勢。

全球Ibuprofen原料藥市場促進因素

全球Ibuprofen原料藥市場正經歷顯著成長，主要驅動力是消費者對經濟實惠的止痛和抗發炎藥物日益成長的需求。專利到期和非專利藥的出現（受醫療保健可負擔性政策的推動）提高了市場可及性。此外，人口老化以及慢性疼痛和發炎相關疾病盛行率的上升進一步加速了市場擴張，提升了市場規模和收入潛力。這些因素共同為全球Ibuprofen原料藥產品的成長與發展創造了強勁的環境。

全球Ibuprofen原料藥市場面臨的限制因素

全球Ibuprofen活性原料藥市場面臨許多挑戰，其中關鍵前驅物（如異丁基苯和乙醯氯）價格的波動尤為顯著。這些價格波動會直接影響生產成本和整體盈利，尤其對中小型生產者而言更是如此。此外，對少數供應商的依賴加劇了供應鏈風險，導致市場環境難以預測且波動劇烈。這種依賴性使得企業難以製定計畫和進行預測，難以應對不斷變化的市場環境，也難以在外部壓力下維持穩定的營運效率。

全球Ibuprofen原料藥市場趨勢

全球Ibuprofen原料藥市場正呈現日益明顯的地域多角化和近岸外包趨勢，買家尋求降低供應鏈風險。這項轉變正在亞太地區打造新的市場格局，中小型製造商紛紛湧現，以提升產能和市場滲透率。同時，在對供應安全和可靠性日益重視的推動下，北美和歐洲的需求也顯著復甦。這種雙管齊下的策略不僅促進了價格競爭和創新，還在Ibuprofen原料藥產業建構了更具韌性的供應鏈框架，重塑了全球貿易動態。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2024 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2024 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2022-2024年營收年比比較

主要企業簡介

BASF SE（Germany）
IOL Chemicals and Pharmaceuticals Limited（IOLCP）（India）
Shandong Xinhua Pharmaceutical Co., Ltd.（China）
Solara Active Pharma Sciences Limited（India）
SI Group, Inc.（United States）
Dr. Reddy's Laboratories Ltd.（India）
Granules India Limited（India）
Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.（China）
Strides Pharma Science Limited（India）
Teva Pharmaceutical Industries Ltd.（Israel）
Pfizer Inc.（United States）
Abbott Laboratories（United States）
BIOCAUSE Inc.（United States）
Mallinckrodt Pharmaceuticals（United States）
SMS Pharmaceuticals Ltd.（India）
Wanbury Limited（India）
Aurobindo Pharma Ltd.（India）
Zhejiang Huahai Pharmaceutical Co., Ltd.（China）
Jubilant Life Sciences Ltd.（India）
Sun Pharmaceutical Industries Ltd.（India）

結論與建議

簡介目錄

Product Code: SQMIG35I2474

Global Ibuprofen API Market size was valued at USD 6.2 billion in 2023 and is poised to grow from USD 6.46 billion in 2024 to USD 8.98 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global Ibuprofen API market is experiencing notable growth driven by increased healthcare access, an aging demographic, and the widespread adoption of generic medications. A surge in demand for anti-inflammatory and analgesic products across both prescription and over-the-counter sectors contributes to this upward trend. Key factors fueling this expansion include the global aging population, enhanced healthcare accessibility, and a preference for cost-effective generic options. North America and Europe hold substantial market shares due to sustained interest in premium APIs, although challenges such as fluctuating raw material costs and regulatory hurdles may threaten operational consistency. The outlook remains optimistic, particularly in the Asia Pacific region, which is poised to lead in production capacity and export volume, influencing market trends in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ibuprofen API market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ibuprofen API Market Segments Analysis

Global Ibuprofen API Market is segmented by Application, Formulation Type and region. Based on Application, the market is segmented into Pharmaceuticals, Consumer Healthcare and Animal Healthcare. Based on Formulation Type, the market is segmented into Tablets, Oral, Suspension and Topical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ibuprofen API Market

The Global Ibuprofen API market is experiencing significant growth, primarily fueled by the rising demand for cost-effective pain relief and anti-inflammatory drugs. The emergence of generic formulations, facilitated by the expiration of patents and efforts to make healthcare more affordable, bolsters market accessibility. Additionally, an aging population and a higher prevalence of chronic pain conditions and inflammation-related disorders further drive the expansion of this market, enhancing both its size and revenue potential. Overall, these factors combine to create a robust environment for the growth and development of Ibuprofen API products worldwide.

Restraints in the Global Ibuprofen API Market

The Global Ibuprofen API market faces significant challenges due to fluctuations in the prices of essential precursors, such as isobutyl benzene and acetyl chloride. These price variations can directly impact production costs and overall profitability, particularly for small- and medium-sized manufacturers. Additionally, the reliance on a limited number of suppliers heightens the exposure to supply chain risks, leading to an unpredictable and unstable market environment. This dependence complicates planning and forecasting efforts, making it difficult for businesses to navigate the evolving landscape and maintain consistent operational efficiency in the face of these external pressures.

Market Trends of the Global Ibuprofen API Market

The Global Ibuprofen API market is witnessing a progressive trend of regional diversification and near-shoring as buyers aim to mitigate supply chain risks. This shift is leading to an evolving market landscape where smaller to mid-sized manufacturers are emerging in the Asia-Pacific region, enhancing production capabilities and market penetration. Concurrently, there is a noticeable resurgence of demand in North America and Europe, driven by a growing emphasis on supply security and reliability. This dual approach not only fosters competitive pricing and innovation but also establishes a more resilient supply chain framework within the ibuprofen API sector, reshaping global trade dynamics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Ibuprofen API Market Size by Application & CAGR (2025-2032)

Market Overview
Pharmaceuticals
Consumer Healthcare
Animal Healthcare

Global Ibuprofen API Market Size by Formulation Type & CAGR (2025-2032)

Market Overview
Tablets
Oral
Suspension
Topical

Global Ibuprofen API Market Size & CAGR (2025-2032)

North America (Application, Formulation Type)
- US
- Canada
Europe (Application, Formulation Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Application, Formulation Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Application, Formulation Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Application, Formulation Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IOL Chemicals and Pharmaceuticals Limited (IOLCP) (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shandong Xinhua Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solara Active Pharma Sciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SI Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Granules India Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Strides Pharma Science Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOCAUSE Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMS Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wanbury Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Life Sciences Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments